Enanta Pharmaceuticals Inc (ENTA) Institutional Buying & Selling Tracker (Q2 2026)

ENTA ranks #4114 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

ENTA is a top-conviction position for Krensavage Asset Management, LLC — at 15.9% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in ENTA belongs to Jupiter Topco LLC, but the position matters far more to Krensavage Asset Management, LLC, who has 15.9% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Spruce Street Capital LP has added to its ENTA position for two straight quarters, increasing it by $9.7M to reach $15.9M today.

Deep Track Capital, LP has trimmed its ENTA position for two straight quarters, cutting it by $9.8M while still holding $21.1M.

ENTA is up 4.3% today, and institutions have been net buyers of $17.7M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

ENTA reported a net loss of $63.2M over the trailing twelve months.

• Not yet profitable — net loss of $63.2M over the trailing twelve months
• Revenue grew 0.7% year over year
• Net income improved year over year, from -$92.0M to -$63.2M
• Operating cash flow was negative, using $19.3M in cash
• Current ratio of 4.21x — enough short-term assets to cover short-term liabilities
• Liabilities run 3.34x equity — a highly leveraged balance sheet worth noting